Artificial Blood Vessels Market Analysis

Material Type (Synthetic, Bioengineered, Hybrid)

In terms of material types, the bioengineered segment is predicted to dominate the artificial blood vessels market with a share of 42.2% by the end of 2037. It offers higher possibilities of attaining affordability in this sector, making this segment the most attractive option for both manufacturers and patients. This leadership is also supported by continuous R&D investments from dedicated organizations. For instance, in 2023, net public and private capital allocation for R&D on bioengineered vessels crossed USD 2.2 million, backed by DARPA and Horizon Europe funding for 3D-printed vascular networks. Furthermore, the sustainable characteristics of this material are accelerating the process of regulatory approvals. For instance, in 2024, 3 acellular vessel products received fast-tracked clearance from the FDA.

Application (Coronary Artery Bypass Grafts (CABG), Peripheral Vascular Repair, Dialysis Access)

Based on applications, the coronary artery bypass grafts (CABG) segment of artificial blood vessels market is anticipated to garner the highest revenue share of 38.4% throughout the analyzed timeframe. The amplifying mortality from CVD is pushing authorities and service providers to fetch long-lasting interventional solutions, such as coronary artery bypass surgeries, fueling demand in this sector. As evidence, in 2024, the WHO revealed that the number of deaths from this disease around the globe was 18.7 million every year. Additionally, the reinforcement strategies, applied by governing bodies, tend to incorporate artificial components, including vessels, ensuring consistent adoption and a stable cash inflow from this segment.

Our in-depth analysis of the global artificial blood vessels market includes the following segments: